Maternal-Child Surveillance and Partnerships for Action, Results, and Knowledge (Forecast)

Maternal-Child Surveillance and Partnerships for Action, Results, and Knowledge (Forecast) is sponsored by Centers for Disease Control - NCBDDD. This forecast grant opportunity from the CDC aims to support maternal and child surveillance and partnerships for action, results, and knowledge. It covers health, youth and child welfare, and statistics and data analysis sectors.

Opportunity Listing - Maternal-Child Surveillance and Partnerships for Action, Results, and Knowledge Maternal-Child Surveillance and Partnerships for Action, Results, and Knowledge Agency: Centers for Disease Control - NCBDDD Assistance Listings: 93. 073 -- Birth Defects and Developmental Disabilities - Prevention and Surveillance Last Updated: July 24, 2026 View version history on Grants.

gov CDC proposes to allocate funds to implement Notice of Funding Opportunity (NOFO) DD-27-0028, Maternal Child Surveillance and Partnerships for Action, Results, and Knowledge .

This NOFO will integrate maternal child health surveillance with national partnership activities to address key public health challenges including alcohol use during pregnancy, fetal alcohol spectrum disorders (FASDs), neonatal abstinence syndrome (NAS), and cytomegalovirus (CMV).

The NOFO will support entities with appropriate data authority and infrastructure to initiate, sustain, enhance, and/or expand clinical surveillance systems capturing data on pregnant women, infants, and/or children. Funding will prioritize improving data quality and enabling timely reporting and dissemination of evolving outcome data.

Funded entities participating in clinical surveillance will monitor prenatal exposures such as alcohol use and polysubstance use during pregnancy as well as conditions with significant public health impact such as FASDs, NAS, congenital CMV, and other outcomes.

CDC will also fund entities with informatics expertise to provide technical assistance to funded entities conducting clinical surveillance, improve data quality, and support dissemination of data through visualizations. Furthermore, this clinical surveillance network could be leveraged to address emerging, reemerging, and persistent public health threats to pregnant women and infants.

In addition, this NOFO will invest in national partnership activities to prevent FASDs and improve early identification as well as support and care of affected infants and children.

Activities may include serving as a national FASD resource; advancing evidence-based messaging; building clinical capacity through a holistic, lifespan approach; addressing regional, state, local, and/or tribal jurisdiction gaps; advancing coordination and translation of activities; and evaluating program strategies.

Together, these activities establish a combined framework that emphasizes data to action approaches that translate high quality surveillance data into prevention strategies, pathways to referral and support, and improved outcomes.

Nonprofits non-higher education without 501(c)(3) Nonprofits non-higher education with 501(c)(3) Other Native American tribal organizations Private institutions of higher education Public and state institutions of higher education Independent school districts Special district governments Public and Indian housing authorities City or township governments Federally recognized Native American tribal governments For-profit organizations other than small businesses The NOFO has three components: Component A, Component B, and Component C.

Eligible applicants may apply for only one component. If an applicant submits multiple applications, all applications submitted by that applicant will be deemed non-responsive, and will not receive further review. In the "Descriptive Title of Applicant's Project" on the SF-424 form, applicants must identify the component and, as applicable, the strategies for which they are applying.

Applicants that do not identify the applicable components and strategies on the SF-424 form will be deemed non-responsive and will not receive further review. Eligible applicants for Component A must have the public health authority, legislative mandate or otherwise show legal access to the requisite data to conduct clinic-based surveillance.

This authority or access must allow unique and specific access to datasets from multiple data sources that are required to implement the activities outlined in this NOFO. Eligible applicants must upload this documentation as a PDF to www. grants.

gov under "Other Attachment Forms" using the attachment name "Legal Authority". CDC will consider any application that does not include this required documentation as non-responsive, and it will receive no further review.

Eligible applicants for Component B must demonstrate their ability and capacity to identify and reach one or more target populations, which include people with FASDs, their families, and/or their communities, as well as clinical and public health professionals, who serve patients or clients who could be impacted by FASDs, across the United States.

Applicants must also demonstrate their ability to develop new communication materials and continually identify and update resources that could be applied to one or more target populations, as well as quantify metrics of impact. Applicant's history of outreach to these populations should include, but may not be limited to, evidence-based educational information, resources, and support.

Eligible applicants for Component C must be able to demonstrate ability to provide informatics and technical support to Component A applicants supporting standardized data collection, quality assurance, and timely data submission. Grantor contact information No documents are currently available.

Link to additional information Estimated Application Due Date : Estimated Due Date Description : Estimated Project Start Date : Funding opportunity number : Cost sharing or matching requirement : Funding instrument type : Opportunity Category Explanation : Category of Funding Activity : Your account requires additional identity verification.